More than 5,000 applications received to participate in the NEUBIAS project coordinated by IRB Barcelona Blog Post

More than 5,000 people have applied to participate in the different training courses offered by the NEUBIAS project, which seeks to expand knowledge in the field of bioimage analysis. Coordinated by IRB Barcelona at PCB, ​​NEUBIAS is the only network of bio-imaging analysts in Europe. It has more than 250 members from 42 countries who share knowledge to improve image analysis technology.

 

Juan Carlos Kaski, new Chief Medical Officer of GlyCardial Diagnostics Blog Post

GlyCardial Diagnostics, based in the Barcelona Science Park, announces the appointment of Prof. Juan Carlos Kaski as Chief Medical Officer. The company –a spinoff of the Research Institute of the Hospital de la Santa Creu i Sant Pau (IR-HSCSP) and the Spanish National Research Council (CSIC), is conducting a clinical trial to validate the performance of Apo J-Glyc as a novel biomarker for the early detection of Myocardial Ischaemia.

 

Nostrum Biodiscovery appoints Ezequiel Mas as its new CEO and embarks on an ambitious expansion plan Blog Post

Nostrum Biodiscovery (NBD) has appointed Ezequiel Mas del Molino as its new CEO to lead a new phase of the company, which is establishing a leading position in the European market as a provider of cutting-edge bioinformatics technologies for drug design and discovery. NBD –a spin-off from the Institute for Research in Biomedicine (IRB Barcelona), the Barcelona Supercomputing Centre (BSC-CNS), the University of Barcelona (UB) and the Catalan Institution for Research and Advanced Studies (ICREA)– is located at the Barcelona Science Park and the North Campus of the Universitat Politècnica de Catalunya (UPC).

 

The PCB’s scientific community joins the fight against SARS-CoV-2 Blog Post

In response to the health emergency caused by SARS-CoV-2, research centres and biotech companies in the Barcelona Science Park (Parc Científic de Barcelona, PCB) are leading scientific progress in the treatment, vaccination and diagnosis of the novel coronavirus. The PCB will ensure that public centres and businesses can continue with their research projects by providing the resources and services they need.

 

IBEC and EMBL brought together more than 150 worldwide experts to debate on the medicine of the future Blog Post

This week, the EMBL-IBEC Winter Conference –organised by the Institute for Bioengineering of Catalonia (IBEC) and the European Molecular Biology Laboratory (EMBL)– brought together more than 200 international experts in the field of bioengineering at La Pedrera building in Barcelona. At the opening of the event, which was led by the mayor Ada Colau, attention was drawn to Barcelona’s consolidation as an international centre of research and knowledge.

 

Launch of the ODISSeA Postgraduate Programme on Organ Donation to train experts in Southeast Asia Blog Post

About three hundred experts from Malaysia, Myanmar, Philippines and Thailand will be the first generation to complete the ODISSeA Postgraduate Programme in Organ Donation. This initiative is carried out as part of the project ODISSeA, led by the University of Barcelona and promote by DTI Foundation–Donation & Transplantation Institute, based in the Barcelona Science Park, to boost highly specialized training among professionals in this field to the countries of Southeast Asia.

 

IBEC signs an agreement with ICMS of TU Eindhoven to foster their collaboration Blog Post

The Institute for Bioengineering of Catalonia (IBEC), based in the Barcelona Science Park, and the Institute of Complex Molecular Systems (ICMS) at Eindhoven University of Technology, have signed the first agreement between the two institutes to foster their collaboration. This institutional alliance will allow to share resources, knowledge and provide mobility programs.

 

Droplite gets €236,000 from the Neotec programme and the European Commission’s Seal of Excellence Blog Post

DROPLITE, a spin-off from the Institute of Photonic Sciences (ICFO) located in the Barcelona Science Park (PCB), has won a €236,000 grant from the Centre for the Development of Industrial Technology (CDTI) in the latest NEOTEC. The company has also earned the European Commission’s Seal of Excellence, which is awarded to start-ups that have first-class innovation ideas with great potential to open up new markets.

 

Nostrum Biodiscovery joins Barcelona Science Park Blog Post

Nostrum Biodiscovery, a spin-off created thanks to the transfer of technology from the Institute for Research in Biomedicine (IRB Barcelona) and the Barcelona Supercomputing Center (BSC-CNS), has moved to Barcelona Science Park. Combining its own technologies with the best modelling software on the market, the company provides in silico services to pharmaceutical and biotechnology companies to accelerate and optimise the design of therapeutic molecules and enzymes, and overcome the common “bottlenecks” in the most initial stages of drug discovery.